CNTY-101

· Century Therapeutics, Inc

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CNTY-101, covering 2025-12-18 to 2026-01-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases [Phase 1]